AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 62 filers reported holding AMPIO PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.28 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $6,000 | -33.3% | 13,488 | -11.1% | 0.00% | – |
| Q4 2021 | $9,000 | -75.0% | 15,169 | -29.4% | 0.00% | – |
| Q3 2021 | $36,000 | -2.7% | 21,487 | -3.3% | 0.00% | – |
| Q2 2021 | $37,000 | -92.4% | 22,216 | -65.4% | 0.00% | -100.0% |
| Q1 2015 | $484,000 | +118.0% | 64,281 | -0.5% | 0.00% | – |
| Q4 2014 | $222,000 | -32.5% | 64,625 | -30.7% | 0.00% | -100.0% |
| Q3 2014 | $329,000 | +1.9% | 93,313 | +141.1% | 0.00% | 0.0% |
| Q2 2014 | $323,000 | +92.3% | 38,703 | +46.7% | 0.00% | – |
| Q1 2014 | $168,000 | -10.6% | 26,385 | -0.1% | 0.00% | – |
| Q4 2013 | $188,000 | -15.3% | 26,399 | -10.8% | 0.00% | -100.0% |
| Q3 2013 | $222,000 | +26.9% | 29,599 | -2.5% | 0.00% | 0.0% |
| Q2 2013 | $175,000 | – | 30,347 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,595,484 | $10,564,000 | 9.31% |
| Cypress Capital Management LLC (WY) | 108,400 | $441,000 | 0.50% |
| Noven Financial Group, Inc. | 158,059 | $643,000 | 0.37% |
| Transform Wealth, LLC | 205,481 | $836,000 | 0.15% |
| GHP Investment Advisors, Inc. | 100,000 | $407,000 | 0.06% |
| Pratt Collard Advisory Partners LLC | 15,600 | $63,000 | 0.05% |
| JANICZEK WEALTH MANAGEMENT, LLC | 16,719 | $68,000 | 0.04% |
| Virtu Financial LLC | 92,344 | $376,000 | 0.02% |
| JFS WEALTH ADVISORS, LLC | 18,150 | $74,000 | 0.02% |
| CONDOR CAPITAL MANAGEMENT | 21,400 | $87,000 | 0.02% |